Bruker Base Upsell Bruker acquired Spectral Instruments Imaging and now owns an installed base of over two hundred preclinical systems. This creates a major opportunity to upsell Aura software modules, Kinetics features, and optics upgrades across Bruker’s customer network, leveraging Bruker’s sales channels and service footprint.

Aura 4.5 Growth Aura 4.5 with Kinetics represents a compelling upgrade path for labs seeking higher throughput and richer kinetic data; target Bruker customers as a value-add upgrade with bundled training and implementation support.

Pharma CRO Targeting The company focuses on preclinical bioluminescent, fluorescent, and x-ray imaging, aligning with pharma and CRO pipelines; pursue outreach to these segments via Bruker’s relationships for system optimization, maintenance contracts, and software upgrade opportunities.

High Throughput Value The advanced optics and high-sensitivity design enable faster screening and scalable workflows; present opportunities to labs requiring throughput gains, data quality improvements, and integrated software-hardware solutions.

Channel Synergy Leverage Bruker’s global sales and service network to co-market and deploy integrated imaging solutions, including hardware, Aura software updates, and service agreements, across regions and key accounts in biotech and life-science research.